Multiple sclerosis epidemiology in Middle East and North Africa: A systematic review and meta-analysis

Neuroepidemiology

Volumn 44, Issue 4, 2015, Pages 232-244

  Heydarpour, Pouria ^a   Khoshkish, Shayan ^a   Abtahi, Shabnam ^a   Moradi Lakeh, Maziar ^b   Sahraian, Mohammad Ali ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Middle East; Multiple sclerosis; North Africa; Prevalence

Indexed keywords

ADULT; AGE; ALGERIA; ATAXIA; BLURRED VISION; CEREBELLAR ATAXIA; DIPLOPIA; EGYPT; FEMALE; HEMIPLEGIA; HUMAN; INCIDENCE; IRAN; IRAQ; JORDAN; KUWAIT; LEBANON; LIBYAN ARAB JAMAHIRIYA; MALE; MCDONALDS CRITERIA; META ANALYSIS; MIDDLE EAST; MULTICENTER STUDY (TOPIC); MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE ASSESSMENT; NORTH AFRICA; OMAN; OPTIC NEURITIS; PREVALENCE; PYRAMIDAL SIGN; QATAR; REVIEW; SAUDI ARABIA; SENSORY DYSFUNCTION; SEX DIFFERENCE; SPATIOTEMPORAL ANALYSIS; SUDAN; SYSTEMATIC REVIEW; TUNISIA; TURKEY (REPUBLIC); UNITED ARAB EMIRATES; WEAKNESS; AFRICA; ONSET AGE; YOUNG ADULT;

ADULT; AFRICA, NORTHERN; AGE OF ONSET; FEMALE; HUMANS; MALE; MIDDLE EAST; MULTIPLE SCLEROSIS; SEX FACTORS; YOUNG ADULT;

EID: 84931858656     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000431042     Document Type: Review

References (72)

1. Dutta R, Trapp BD: Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 2007; 68(suppl 3):S22-S31; discussion S43-S54.
2. Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 1996; 46: 907-911.
3. Noseworthy JH, et al: Multiple sclerosis. N Engl J Med 2000; 343: 938-952.
4. Koch-Henriksen N, Sørensen PS: The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010; 9: 520-532.
5. Orton SM, et al: Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006; 5: 932-936.
6. Browne P, et al: Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology 2014;83:1022-1024.
7. Etemadifar M, Maghzi AH: Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler 2011; 17: 1022-1027.
8. Heydarpour P, et al: Multiple sclerosis in Tehran, Iran: a joinpoint trend analysis. Mult Scler 2014; 20: 512.
9. Etemadifar M, et al: Multiple sclerosis in Isfahan, Iran: an update. Mult Scler 2013; 20: 1145-1147.
10. Deleu D, et al: Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler 2013; 19: 816-819.
11. Alroughani R, et al: Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Mult Scler 2014; 20: 543-547.
12. Ebers GC: Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268-277.
13. Murray CJ, et al: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012; 380: 2197-2223.
14. Poser CM, et al: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
15. McDonald WI, et al: Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
16. Polman CH, et al: Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'Mc-Donald criteria'. Ann Neurol 2005; 58: 840-846.
17. Polman CH, et al: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
18. Kingwell E, et al: Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol 2013; 13: 128.
19. Evans C, et al: Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology 2013; 40: 195-210.
20. Cristiano E, Patrucco L, Rojas JI: A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol 2008; 15: 1273-1278.
21. WHO: WHO Regions by LMIC, 2014. http://www.who.int/phe/health-topics/outdoorair/databases/country-grouping-May2014.pdf (cited April 17, 2015).
22. WHO: Analysis Categories and Mortality Data Sources, 2004. http://www.who.int/healthinfo/global-burden-disease/GBD-report-2004update-AnnexC.pdf?ua=1 (cited April 17, 2015).
23. The Joanna Briggs Institute: The Joanna Briggs Institute Reviewers' Manual: 2014 Edition/Supplement, 2014.
24. Tallawy HN, et al: Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt. Neuropsychiatr Dis Treat 2013; 9: 767-771.
25. Recep ALP, Selen Ilhan ALP, Planci Y, Yapici Z, Börü UT: The prevalence of multiple sclerosis in the north Caucasus region of Turkey: door-to-door epidemiological field study. Nöropsikiyatri Arşivi 2012; 49: 272-275.
26. Börü UT, et al: Prevalence of multiple sclerosis: door-to-door survey in three rural areas of coastal Black Sea regions of Turkey. Neuroepidemiology 2011; 37: 231-235.
27. Türk Börü U, et al: Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology 2006; 27: 17-21.
28. Etemadifar M, et al: Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006; 27: 39-44.
29. Elhami SR, et al: A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 2011; 36: 141-147.
30. Sahraian MA, et al: Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol 2010; 64: 331-336.
31. Saadatnia M, Etemadifar M, Maghzi AH: Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol 2007; 79: 357-375.
32. Ghandehari K, et al: Prevalence of multiple sclerosis in north east of Iran. Mult Scler 2010; 16: 1525-1526.
33. Ebrahimi HA, Sedighi B: Prevalence of multiple sclerosis and environmental factors in Kerman province, Iran. Neurology Asia 2013; 18: 385-389.
34. Saman-Nezhad B, et al: Epidemiological characteristics of patients with multiple sclerosis in Kermanshah, Iran in 2012. J Mazandaran Univ Med Sci 2013; 23: 97-101.
35. Majdinasab N, Nakhostin-Mortazavi A, Alemzadeh-Ansari MH: Epidemiologic features of multiple sclerosis in south-western Iran; in 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. Lyon, France, 2012.
36. Sharafaddinzadeh N, et al: The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs. Clin Neurol Neurosurg 2013; 115: 1271-1275.
37. Rezaali S, et al: Epidemiology of multiple sclerosis in Qom: demographic study in Iran. Iran J Neurol 2013; 12: 136-143.
38. Hashemilar M, Ouskui DS, Farhoudi M, Ayromlou H, Asadollahi A: Multiple sclerosis in east Azerbaijan, north west Iran. Neurology Asia 2011; 16: 127-131.
39. Abedini M, Habibi-Saravi R, Zarvani A, Farahmand M: Epidemiology of multiple sclerosis in Mazandran province in 2007 (in Persian). J Mazandaran Univ Med Sci 2008; 18: 82-87.
40. th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis. Amsterdam, The Netherlands, 2011.
41. Hecham N: Descriptive epidemiology of MS patients followed in an Algerian University Hospital; in 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. Gothenburg, Sweden, 2010.
42. Hasan ZN: Disability and prognosis of relapsing remitting multiple sclerosis, is it different in Iraqi patients? Neurosciences (Riyadh) 2011; 16: 233-236.
43. Al-Hamadani HA, Abdalla AS, Al-Saffar AJ: The course of early-onset multiple sclerosis in Iraqi children. World J Pediatr 2012; 8: 47-51.
44. Al-Araji A, Mohammed AI: Multiple sclerosis in Iraq: does it have the same features encountered in Western countries? J Neurol Sci 2005; 234: 67-71.
45. Bahou YG: Multiple sclerosis at Jordan University Hospital. Neurosciences (Riyadh) 2002; 7: 105-108.
46. Alshubaili AF, et al: Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence. Eur Neurol 2005; 53: 125-131.
47. Yamout B, et al: Clinical characteristics of multiple sclerosis in Lebanon. J Neurol Sci 2008; 270: 88-93.
48. Sawaya RA, Kanso MI: Multiple sclerosis in Lebanon: a review of 45 cases. Mult Scler 2009; 15: 279-280.
49. Tharakan JJ, Chand RP, Jacob PC: Multiple sclerosis in Oman. Neurosciences (Riyadh) 2005; 10: 223-225.
50. Tharakan J, Chand P, Jacob PC: Multiple sclerosis in Oman: clinical and epidemiological study. J Neurol Sci 1997; 150(suppl):S188.
51. Akhtar N, et al: Newly diagnosed multiple sclerosis in state of Qatar. Clin Neurol Neurosurg 2013; 115: 1333-1337.
52. Al-deeb S: Epidemiology of MS in Saudi Arabia; in 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. Dusseldorf, Germany, 2009.
53. Daif AK, et al: Pattern of presentation of multiple sclerosis in Saudi Arabia: analysis based on clinical and paraclinical features. Eur Neurol 1998; 39: 182-186.
54. Yaqub BA, Daif AK: Multiple sclerosis in Saudi Arabia. Neurology 1988; 38: 621-623.
55. Inshasi J, Thakre M: Prevalence of multiple sclerosis in Dubai, United Arab Emirates. Int J Neurosci 2011; 121: 393-398.
56. Alroughani R, Ashkanani A, Lamdhade S: Clinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital. Int J Neurosci 2012; 122: 82-87.
57. Hasan ZN, Hasan HA, Sabah AS: Clinical and radiological study of Iraqi multiple sclerosis patients with childhood onset. Neurosciences (Riyadh) 2011; 16: 229-232.
58. Hashem S, El-Tamawy M, Hamdy S, Elmasry T: Epidemiology of multiple sclerosis in Egypt. Egypt J Neurol Psychiatr Neurol 2010; 47: 625-632.
59. Kalanie H, Gharagozli K, Kalanie AR: Multiple sclerosis: report on 200 cases from Iran. Mult Scler 2003; 9: 36-38.
60. Al-Shimmery EK, Bzaini AS: Multiple sclerosis in Jordan and Iraq. Clinical and social overview. Neurosciences (Riyadh) 2008; 13: 276-282.
61. El-Salem K, et al: Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006; 253: 1210-1216.
62. al-Din AS, et al: Multiple sclerosis in Arabs in Jordan. J Neurol Sci 1995; 131: 144-149.
63. Najim Al-Din AS, et al: Epidemiology of multiple sclerosis in Arabs in Jordan: a comparative study between Jordanians and Palestinians. J Neurol Sci 1996; 135: 162-167.
64. al-Din AS, et al: Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians. J Neurol Sci 1990; 100: 137-141.
65. Radhakrishnan K, et al: Prevalence and pattern of multiple sclerosis in Benghazi, northeastern Libya. J Neurol Sci 1985; 70: 39-46.
66. Idris MN, et al: Multiple sclerosis in Sudan: a prospective study of clinical presentation and outcome. Mult Scler 2009; 15: 1537-1538.
67. Sidhom Y, et al: Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course? J Neurol Sci 2014; 343: 110-114.
68. Çelik Y, Birgili Ö, Kiyat A, Güldiken B, Özkan H, Yilmaz H, Saip S, Kusçu D, Sütlas N, Agaoglu J, Utku U, Siva A: Prevalence of multiple sclerosis in the metropolitan area of Edirne City, Turkey. Balkan Med J 2011; 28: 193-196.
69. Izadi S, et al: Significant increase in the prevalence of multiple sclerosis in Iran in 2011. Iran J Med Sci 2014; 39: 152-153.
70. Etemadifar M, et al: Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol 2013; 70: 356-363.
71. Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S: Incidence and prevalence of multiple sclerosis in southeastern Iran. Clin Neurol Neurosurg 2013; 115: 304-308.
72. Moghaddam AH, Iranmanesh F, Vakilian A: Epidemiology of multiple sclerosis in Rafsanjan: South of Iran. Multiple Sclerosis Journal, 2013.